Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States

Annals of Internal Medicine

Volumn 154, Issue 2, 2011, Pages 85-93

  Davila, Jessica A ^a   Henderson, Louise ^b   Kramer, Jennifer R ^a   Kanwal, Fasiha ^c   Richardson, Peter A ^a   Duan, Zhigang ^a   El Serag, Hashem B ^a  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b 2006 Old Clinic   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ALGORITHM; ARTICLE; CANCER EPIDEMIOLOGY; COHORT ANALYSIS; COMORBIDITY; DECOMPENSATED LIVER CIRRHOSIS; DISEASE REGISTRY; ECHOGRAPHY; FOLLOW UP; HEALTH CARE FACILITY; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNITED STATES; VARICOSIS; VETERAN;

EID: 79551648518     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/0003-4819-154-2-201101180-00006     Document Type: Article

References (35)

1. El-Serag HB, Davila JA, Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817-823. [PMID: 14623619]
2. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a populationbased study. Gastroenterology. 2004;127:1372-1380. [PMID: 15521006]
3. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000;160:3227-3230. [PMID: 11088082]
4. Hassan MM, Frome A, Patt YZ, El-Serag HB. Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2002;35:266-269. [PMID: 12192205]
5. Kulkarni K, Barcak E, El-Serag H, Goodgame R. The impact of immigration on the increasing incidence of hepatocellular carcinoma in the United States. Aliment Pharmacol Ther. 2004;20:445-450. [PMID: 15298639]
6. Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. Surgery for hepatocellular carcinoma: does it improve survival? Ann Surg Oncol. 2004;11:298-303. [PMID: 14993025]
7. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, et al; EASL Panel of Experts on HCC. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-430. [PMID: 11592607]
8. Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. [PMID: 16250051]
9. Colombo M. Screening for hepatocellular carcinoma. Digestion. 1998;59 Suppl 2:70-71. [PMID: 9718427]
10. McMahon BJ, London T. Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst. 1991;83:916-919. [PMID: 1712399]
11. Nguyen MH, Keeffe EB. Screening for hepatocellular carcinoma. J Clin Gastroenterol. 2002;35:S86-S91. [PMID: 12394211]
12. Ryder SD; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52 Suppl 3:iii1-8. [PMID: 12692148]
13. Sherman M. Screening for hepatocellular carcinoma. Baillieres Best Pract Res Clin Gastroenterol. 1999;13:623-635. [PMID: 10654924]
14. Tong MJ, Blatt LM, Kao VW. Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America. J Gastroenterol Hepatol. 2001;16:553-559. [PMID: 11350553]
15. Trevisani F, De NS, Rapaccini G, Farinati F, Benvegnù L., Zoli M, et al; Italian Liver Cancer Group. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience). Am J Gastroenterol. 2002;97:734-744. [PMID: 11922571]
16. Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, et al; Italian Liver Cancer (ITALICA) group. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol. 2004;99:1470-1476. [PMID: 15307862]
17. Wong LL, Limm WM, Severino R, Wong LM. Improved survival with screening for hepatocellular carcinoma. Liver Transpl. 2000;6:320-325. [PMID: 10827233]
18. Yang B, Zhang B, Xu Y, Wang W, Shen Y, Zhang A, et al. Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol. 1997; 123:357-S360. [PMID: 9222303]
19. Yu EW, Chie WC, Chen TH. Does screening or surveillance for primary hepatocellular carcinoma with ultrasonography improve the prognosis of patients? Cancer J. 2004;10:317-325. [PMID: 15530261]
20. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience. Hepatology. 2000;31:330-335. [PMID: 10655254]
21. Zhang BH, Yang BH, Tang ZY. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol. 2004;130:417-422. [PMID: 15042359]
22. Davila JA, Weston A, Smalley W, El-Serag HB. Utilization of screening for hepatocellular carcinoma in the United States. J Clin Gastroenterol. 2007;41: 777-782. [PMID: 17700427]
23. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology. 2010;52:132-141. [PMID: 20578139]
24. Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP. Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. Clin Gastroenterol Hepatol. 2007;5:508-512. [PMID: 17382601]
25. Backus LI, Gavrilov S, Loomis TP, Halloran JP, Phillips BR, Belperio PS, et al. Clinical Case Registries: simultaneous local and national disease registries for population quality management. J Am Med Inform Assoc. 2009;16:775-783. [PMID: 19717794]
26. Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008;27:274-282. [PMID: 17996017]
27. VA Information Resource Center. VA/CMS Data for Research. Accessed at www.virec.research.va.gov/ on 17 June 2010.
28. Harman HH. Modern Factor Analysis. 3rd ed. Chicago: Univ Chicago Pr; 1976.
29. Richardson P, Henderson L, Davila JA, Kramer JR, Fitton CP, Chen GJ, et al. Surveillance for hepatocellular carcinoma: development and validation of an algorithm to classify tests in administrative and laboratory data. Dig Dis Sci. 2010;55:3241-3251. [PMID: 20844957]
30. United Network for Organ Sharing. MELD/PELD Calculator. Accessed at www.unos.org/resources/meldpeldcalculator.asp on 17 June 2010.
31. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619. [PMID: 1607900]
32. Chalasani N, Horlander JC Sr, Said A, Hoen H, Kopecky KK, Stockberger SM Jr, et al. Screening for hepatocellular carcinoma in patients with advanced cirrhosis. Am J Gastroenterol. 1999;94:2988-2993. [PMID: 10520857]
33. Bruix J, Sala M, Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology. 2004;127:S179-S188. [PMID: 15508083]
34. Livraghi T, Bolondi L, Buscarini L, Cottone M, Mazziotti A, Morabito A, et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group. J Hepatol. 1995;22:522-526. [PMID: 7650331]
35. Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, et al; Italian Liver Cancer Group. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? Am J Gastroenterol. 2007;102:2448-2457. [PMID: 17617210]